Home > News > US nanotechnology leader joins DNT Board
December 15th, 2003
US nanotechnology leader joins DNT Board
Abstract:
Starpharma Pooled Development Limited is pleased to announce that Prof Jean Fréchet has joined the
Board of Dendritic Nanotechnologies, Inc. (DNT), the US nanotechnology company in which Starpharma has a 49.9% equity interest. Starpharma CEO Dr John Raff said: “Prof Fréchet has outstanding scientific credentials in addition to extensive experience and involvement in commercial and venture capital areas. His appointment to the Board of DNT complements other recent high profile commercial appointments, and further consolidates DNT as a significant participant in the US nanotechnology industry." (PDF)
Source:
SPL
Bookmark:
Appointments/Promotions/New hires/Resignations/Deaths
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
Solid-State Lighting Expert Dr. Bernhard Stapp Named To Board of Pioneering LED Technology Developer Aledia: Former OSRAM General Manager and CTO Has Played Key Role In Industry’s Evolution, Will Aid Aledia’s Move Towards Industrialization May 22nd, 2013
Applied Nanotech Seeks New Chief Executive Officer: New Leader Needed for Next Phase of Growth May 10th, 2013
Cambrios Taps Sriram Peruvemba to Oversee Worldwide Marketing May 8th, 2013